
Ob/gyn patients undergo ultrasounds for a number of reasons. Because of the small variety of closely related U/S codes, successful billing for more than one U/S depends on the diagnosis and documentation.

Ob/gyn patients undergo ultrasounds for a number of reasons. Because of the small variety of closely related U/S codes, successful billing for more than one U/S depends on the diagnosis and documentation.

Although CPT 2002 introduced specific new codes for fine-needle aspiration (FNA), those codes didn't clear up much of the confusion about how they apply.

Clinical meeting ACOG

Acquired and inherited thrombophilias can be related to repeat miscarriage. Knowing which mutations to look for and who and when to screen are key, although treatment remains controversial.

Coding and reimbursement for Medicare well-woman screening exams is one of the biggest challenges in ob/gyn coding. You must know whether a patient meets Medicare's criteria for "high risk" or "low risk." This risk factor determines the frequency with which Medicare pays for well-woman care.

Whether the etiology is androgen excess or something more benign, excess hair growth negatively impacts quality of life for millions of women. A thorough evaluation is required to uncover underlying causes and provide appropriate treatment.

When stomach, liver, or intestines herniate into the chest cavity of a fetus with this anomaly, they compress the fetal lung.

News Briefs


Can you get insurers to pay you for a procedure like endometrial biopsy performed at the same time as a problem-oriented visit? Sometimes. Be sure to bone up first on the intricacies of proper coding.

Who should undergo genetic testing? Before ordering it, three conditions should be met: There should be a greater than 10% likelihood of a positive test; the ordering physician should be able to interpret the result; and the information should be used to make management decisions.

Myotonic dystrophy (DM) is the most comnmon muscular dystrophy seen in adults.

Here's how to identify fetuses affected with one of the three major sickle hemoglobinopathies--along with antepartum and intrapartum management strategies to improve maternal and perinatal outcome.

While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.

How to care for the HIV-infected pregnant patient

editorial



Predicting medical disorders in utero
